View this API's:

Patents at Patent & Trademark Office Patent/Exclusivity data file Drug Approval Drug Safety Freedom of Information Federal Register pages Pharma Companies Pharmacopeial Information Preferred API Supplier (Clients Only)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Start and Thesaurus | Brand Names | DMF Index | Search | Pharma Industry Portals | Site Map

 

FDA Approval Activities for this Drug… Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S032 5/24/02 6/3/02 Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S031 8/20/03 8/28/03 Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S30 1/8/04 1/9/04 Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S27 12/3/03 12/8/03 Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S022 12/15/99 6/22/01 Norvasc (amlodipine besylate) Tablets, Rx Pfizer NDA 19-787/S021 2/1/00 6/6/01 Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S019 9/7/99 8/6/03 Norvasc (amlodipine besylate) Tablets, 2.5, 5, & 10 mg, Rx Pfizer Inc. NDA 19-787/S018 6/4/99 6/22/01 Norvasc (amlodipine besylate) Tablets, Rx Pfizer NDA 19-787/S017 & S020 7/12/00 7/14/00 6/4/01 Norvasc Indications: Supplement provided for extensive revisions of the PRECAUTIONS: Drug Interactions subsection AMLODIPINE BESYLATE TABLET; ORAL EQ 10MG BASE NORVASC PFIZER 019787 No AMLODIPINE BESYLATE TABLET; ORAL EQ 2.5MG BASE NORVASC PFIZER 019787 No AMLODIPINE BESYLATE TABLET; ORAL EQ 5MG BASE NORVASC PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 10MG BASE;EQ 10MG BASE CADUET PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 10MG BASE;EQ 20MG BASE CADUET PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 10MG BASE;EQ 40MG BASE CADUET PFIZER 021540 Yes AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 10MG BASE;EQ 80MG BASE CADUET PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 5MG BASE;EQ 10MG BASE CADUET PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 5MG BASE;EQ 20MG BASE CADUET PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 5MG BASE;EQ 40MG BASE CADUET PFIZER 021540 No AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TABLET; ORAL EQ 5MG BASE;EQ 80MG BASE CADUET PFIZER 020364 Yes AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE CAPSULE; ORAL EQ 10MG BASE;20MG LOTREL NOVARTIS 020364 No AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE CAPSULE; ORAL EQ 2.5MG BASE;10MG LOTREL NOVARTIS 020364 No AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE CAPSULE; ORAL EQ 5MG BASE;10MG LOTREL NOVARTIS 020364 No AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE CAPSULE; ORAL EQ 5MG BASE;20MG LOTREL NOVARTIS Lotrel (amlodipine and benazepril HCl) Capsules, 2.5/10mg, 5/10 mg, and 5/20 mg, Rx Novartis Pharmaceuticals Corporation NDA 20-364/S-016 6/20/02 6/24/02 11/18/02 11/22/02 Lotrel (amlodipine and benazepril HCl) Capsules, Rx Novartis Pharmaceuticals Corporation NDA 20-364/S-014 8/29/03 9/9/03 Lotrel (Amiodipine Besylate/Benazepril Hydrochloride) Capsules Novartis Pharmaceuticals Corp. NDA 20-364/S008 6/16/99 8/21/01 Lotrel (amlodipine and benazepril HCl) Capsules, Novartis Pharmaceuticals Labeling Revision Lotrel (amlodipine besylate and benazepril hydrochloride) Capsules, Novartis Pharmaceuticals, Labeling Revision   For the latest approval information, locate this drug using this index.